rifapentine (Compound)

Synonyms:RIFAPENTINE, Priftin, 61379-65-5, Cyclopentylrifampicin, Rifapentin, MDL 473, Priftin (TN), Rifamycin AF/ACPP, CHEBI:45304, MDL-473, 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin, DL 473, KTC 1, UNII-XJM390A33U, XJM390A33U, Cyclopentyl rifampin, DL-473, R-773, R 77-3, Rifapentina, Rifapentinum, [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate, C47H64N4O12, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate, DL 473;Cyclopentylrifampicin, MDL473, 3-(N-(4-Cyclopentyl-1-piperazinyl)formimidoyl)rifamycin, 3-[N-(4-Cyclopentyl-1-piperazinyl)formimidoyl]rifamycin, NCGC00167431-01, Rifapentinum [Latin], Rifapentina [Spanish], Antibiotic DL 473IT, Rifapentine (USAN/INN), 3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV, CHEMBL1660, DSSTox_CID_21115, DSSTox_RID_79627, KTC-1, DSSTox_GSID_41115, SCHEMBL41590, ANTIBIOTIC DL-473IT, Rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-, Rifapentine [USAN:INN:BAN], DTXSID8041115, DL473, HMS3713M16, DRG-0283, EINECS 262-743-9, Tox21_112435, BDBM50248298, MFCD00866806, AKOS024255723, CCG-220467, DB01201, KS-1409, CAS-61379-65-5, C08059, D00879, J90035, R-77-3, AB01209744-01, AB01209744-03, AB01209744_04, 379R655, M000473, Rifapentine, Antibiotic for Culture Media Use Only, W-105162, (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate, [[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl] acetate, 1279038-35-5, RPE

Pubchem:PUBCHEM:136238508

Id:ffd3e6c6-0155-58c6-9c8a-7aa265cc24e6

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View rifapentine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for rifapentine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with rifapentine.

Results found

Linked to

	Label	Description
	DCSTRUCT ID 02378 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02378; PubChem_CID:135403821, FILE=drugcentral_drug_02378.json)
	rifapentine positively regulates TXNDC9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine positively regulates MT1H Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine negatively regulates HSPB8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine negatively regulates PDLIM3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine positively regulates HAL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine negatively regulates COL4A5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine negatively regulates IFITM3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine positively regulates MT1HL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rifapentine negatively regulates MEIS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS